FTC warns 24 healthcare companies over price disclosures

The U.S. regulator says meeting CMS price-transparency rules does not exempt providers from liability for unfair or deceptive practices under the FTC Act.

The U.S. regulator says meeting CMS price-transparency rules does not exempt providers from liability for unfair or deceptive practices under the FTC Act.
The U.S. Federal Trade Commission warned 24 of the country’s largest healthcare services companies on October 5, 2026, that incomplete, inaccurate or late price disclosures may violate the FTC Act. The letters, sent by FTC Chairman Andrew N. Ferguson, focus particularly on routine, non-emergency care scheduled in advance.
According to the FTC, price-transparency rules set by the Centers for Medicare & Medicaid Services (CMS) provide a baseline for healthcare facilities. Meeting those rules does not necessarily satisfy Section 5 of the FTC Act, which addresses unfair or deceptive practices. The agency says CMS compliance offers no “safe harbor”—protection from liability under the FTC Act.
The letters say price is an important term of a healthcare transaction, so disclosures often need to be clear and easy to notice. Leaving out a price may be deceptive if doing so is likely to mislead patients acting reasonably in the circumstances.
Providing a figure is not enough if patients could reasonably understand it as the total cost but it leaves out charges, the FTC warns. Its examples include omitted physician or facility fees and prices covering only part of the expected course of care. Inaccurate prices are also misleading, the agency says.
Timing matters because patients need an opportunity to compare providers before committing to scheduled care. The FTC says incomplete, inaccurate or insufficiently early information prevents those comparisons and informed decisions. Its warning about timing concerns price information reasonably available to the provider in advance.
The FTC also says nontransparent pricing may be unfair under Section 5 when it causes, or is likely to cause, substantial harm that consumers cannot reasonably avoid and that is not outweighed by benefits to consumers or competition.
The letters warn about existing obligations; they do not introduce new rules or establish that the recipients violated the law. The FTC’s announcement did not name the recipients or give their responses. Ferguson urged the companies to comprehensively review their price-disclosure practices and take swift corrective action where needed.

Microsoft is directing employees toward its own tools and OpenAI models, while Meta promotes internal alternatives.
2 min

The city has no major renovation plans through at least 2027 for the road to Armenia’s Anti-Corruption Court. Smaller repairs and heavy-truck controls remain unanswered.

A shooting in Kotayk injured two patrol officers. The available 2026 count covers only seven months and does not establish a year-on-year increase.
2 min